Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
31.09
+0.20 (0.65%)
Oct 11, 2024, 4:00 PM EDT - Market closed
Immunocore Holdings Employees
Immunocore Holdings had 497 employees as of December 31, 2023. The number of employees increased by 89 or 21.81% compared to the previous year.
Employees
497
Change (1Y)
89
Growth (1Y)
21.81%
Revenue / Employee
$565,219
Profits / Employee
-$110,414
Market Cap
1.56B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Integra LifeSciences Holdings | 3,946 |
| NovoCure | 1,453 |
| STAAR Surgical Company | 1,057 |
| GeneDx Holdings | 1,000 |
| CareDx | 643 |
| Arcus Biosciences | 577 |
| Progyny | 566 |
| Rocket Pharmaceuticals | 268 |
IMCR News
- 4 weeks ago - Immunocore presents Phase 1 data of brenetafusp, an ImmTAC bispecific targeting PRAME, in patients with ovarian cancer - GlobeNewsWire
- 4 weeks ago - Immunocore to present at the 2024 Cantor Global Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Immunocore: Pipeline Expands HLA Tumor Targeting Beyond Kimmtrak - Seeking Alpha
- 2 months ago - Immunocore Holdings: KIMMTRAK Success, Diverse Pipeline, And Potential Big Pharma Appeal - Seeking Alpha
- 2 months ago - Immunocore Holdings plc (IMCR) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response - GlobeNewsWire
- 4 months ago - Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting PRAME, in immune checkpoint pre-treated cutaneous melanoma patients at ASCO 2024 - GlobeNewsWire
- 4 months ago - Immunocore to present at the Jefferies Global Healthcare Conference - GlobeNewsWire